Management of Essential Tremor prioritizes functional improvement over symptom elimination, and protocols begin with ...
Detailed price information for Monte Rosa Therapeutics Inc (GLUE-Q) from The Globe and Mail including charting and trades.
Foresee Pharmaceuticals has shown that a long-acting version of its injectable prostate cancer med Camcevi can help patients ...
A NOVEL study has identified two genes, Apolipoprotein C1 (APOC1) and Nucleolar Protein 16 (NOP16), as potential early diagnostic markers for prostate cancer, offering a possible advance in detection ...
ABSTRACT: Introduction: Lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH) is one among the foremost common diseases affecting the aging man with, almost 80% of the ...
Controversial creator Scott Adams, the cartoonist best known for “Dilbert,” is paralyzed. On Saturday, the cartoonist, 68, said on social media that he is “paralyzed below the waist” in the wake of ...
Rubraca is now FDA-approved for BRCA mutation-associated mCRPC after prior androgen receptor-directed therapy, confirming its efficacy in the TRITON3 trial. The TRITON3 trial showed Rubraca ...
All 20 patients enrolled were evaluable for safety. The combination of MRT-2359 and enzalutamide maintained a favorable safety profile, with manageable, primarily gastrointestinal adverse events that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback